Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
About this item
Full title
Author / Creator
Gler, Maria Tarcela , Skripconoka, Vija , Sanchez-Garavito, Epifanio , Xiao, Heping , Cabrera-Rivero, Jose L , Vargas-Vasquez, Dante E , Gao, Mengqiu , Awad, Mohamed , Park, Seung-Kyu , Shim, Tae Sun , Suh, Gee Young , Danilovits, Manfred , Ogata, Hideo , Kurve, Anu , Chang, Joon , Suzuki, Katsuhiro , Tupasi, Thelma , Koh, Won-Jung , Seaworth, Barbara , Geiter, Lawrence J and Wells, Charles D
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this report on the treatment of multidrug-resistant (MDR) tuberculosis, the authors found that delamanid, a novel anti-TB medication, led to more rapid sputum culture conversion to negative when added to a background regimen than the background regimen alone.
The emergence over the past two decades of multidrug-resistant tuberculosis, or tube...
Alternative Titles
Full title
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Authors, Artists and Contributors
Author / Creator
Skripconoka, Vija
Sanchez-Garavito, Epifanio
Xiao, Heping
Cabrera-Rivero, Jose L
Vargas-Vasquez, Dante E
Gao, Mengqiu
Awad, Mohamed
Park, Seung-Kyu
Shim, Tae Sun
Suh, Gee Young
Danilovits, Manfred
Ogata, Hideo
Kurve, Anu
Chang, Joon
Suzuki, Katsuhiro
Tupasi, Thelma
Koh, Won-Jung
Seaworth, Barbara
Geiter, Lawrence J
Wells, Charles D
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1019619787
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1019619787
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1112433
